Literature DB >> 30279833

A case of upper extremity deep vein thrombosis with long-term patency using pharmaco-mechanical catheter-directed thrombolysis in the acute phase.

Tomoya Hasegawa1, Hiroaki Tabata1, Mitsuru Kagoshima1.   

Abstract

Although upper-extremity deep vein thrombosis (UEDVT) is considered rare, its prevalence appears to be increasing, and this may be related to expanding indications for catheter-based interventions. In contrast, few cases have been reported related to strenuous exercise, especially in healthy young adults with thoracic outlet syndrome (Paget-Schroetter syndrome). In contrast to lower-extremity DVT, optimal treatment strategies for UEDVT have not been robustly studied. In this report, we describe a 56-year-old man with primary UEDVT presenting with left arm swelling, paresthesia, and visible collateral veins around the shoulder. Venography revealed thrombotic occlusion of the left subclavian vein. Emergent pharmaco-mechanical catheter-directed thrombolysis (PCDT) was performed, and his left subclavian vein was recanalized. A novel oral anticoagulant was initiated to prevent reclosure. The patient's symptoms subsided without major bleeding complications and at six months, he has no disability for daily activities. Follow-up ultrasonography revealed almost complete patency of the left subclavian vein, after which anticoagulation therapy was terminated. We discuss the role of PCDT in the management of primary UEDVT from the perspective of efficacy and contribution to quality of life. <Learning objective: UEDVT is relatively rare and has not been examined as extensively as lower-extremity DVT. Nonetheless, patients may have a variety of unpleasant symptoms that substantially decrease quality of life. Pharmaco-mechanical catheter-directed thrombolysis may be effective to reduce clot burden and mitigate the risk of post-thrombotic syndrome. Although there is no current consensus about exact indications for UEDVT patients, the procedure may be more useful than the standard anticoagulant therapy.>.

Entities:  

Keywords:  Catheter-directed thrombolysis/Pharmaco-mechanical catheter-directed thrombolysis; Effort-related thrombosis (Paget-Schroetter syndrome); Venous thoracic outlet syndrome

Year:  2017        PMID: 30279833      PMCID: PMC6149553          DOI: 10.1016/j.jccase.2017.08.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  12 in total

Review 1.  Clinical practice. Deep-vein thrombosis of the upper extremities.

Authors:  Nils Kucher
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

Review 2.  Management of deep vein thrombosis of the upper extremity.

Authors:  Rolf P Engelberger; Nils Kucher
Journal:  Circulation       Date:  2012-08-07       Impact factor: 29.690

3.  The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.

Authors:  Susan R Kahn; Anthony J Comerota; Mary Cushman; Natalie S Evans; Jeffrey S Ginsberg; Neil A Goldenberg; Deepak K Gupta; Paolo Prandoni; Suresh Vedantham; M Eileen Walsh; Jeffrey I Weitz
Journal:  Circulation       Date:  2014-09-22       Impact factor: 29.690

Review 4.  The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review.

Authors:  Elyssa E Elman; Susan R Kahn
Journal:  Thromb Res       Date:  2005-07-06       Impact factor: 3.944

Review 5.  Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis.

Authors:  Benjamin O Patterson; Robert Hinchliffe; Ian M Loftus; Matt M Thompson; Peter J E Holt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04       Impact factor: 8.311

6.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

7.  Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion (TORPEDO) trial: midterm results.

Authors:  Mohsen Sharifi; Curt Bay; Mahshid Mehdipour; Jalaladdin Sharifi
Journal:  J Endovasc Ther       Date:  2012-04       Impact factor: 3.487

8.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Authors:  Tone Enden; Ylva Haig; Nils-Einar Kløw; Carl-Erik Slagsvold; Leiv Sandvik; Waleed Ghanima; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet       Date:  2011-12-13       Impact factor: 79.321

9.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Susan R Kahn; Jim Julian; Elizabeth Magnuson; Michael R Jaff; Timothy P Murphy; David J Cohen; Anthony J Comerota; Heather L Gornik; Mahmood K Razavi; Lawrence Lewis; Clive Kearon
Journal:  Am Heart J       Date:  2013-03-05       Impact factor: 4.749

10.  Systemic thrombolysis in the upper extremity deep vein thrombosis.

Authors:  Roxana Sadeghi; Morteza Safi
Journal:  ARYA Atheroscler       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.